Acal BFi inks channel partner agreement in Europe with SynQor

Acal BFi, European leader in advanced technology solutions, have signed a channel partner agreement in Europe with SynQor to include UK, Ireland, Denmark, Sweden, Norway, Finland, Belgium, Netherlands, Luxemburg and Italy.

SynQor is a world-leader in high-efficiency, high-reliability power conversion solutions, designing, engineering and manufacturing all of its products in the USA. The company's extensive product portfolio contains a lot of industry-firsts and is designed to excel in demanding environments - ideal for applications within the military, industrial, transportation, medical and communications markets. SynQor's high quality products follow an elaborate platform strategy, which allows easy, fast and inexpensive design adaptions to application needs - and ultimately results in an extraordinary high launch rate of product innovations.

Robert Rohde, European Business Development Director - Power and Magnetics at Acal BFi said: "We are delighted to be appointed as SynQor's strategic distributor. The addition of their innovative product range of DC-DC converters, EMI filters, AC/DC supplies and military power systems, specifically tailored to the railway, military and medical sectors, complements Acal BFi's current power portfolio."

Rene Hemond, EVP of SynQor said: "SynQor is pleased to partner with Acal BFi to distribute our product lines in UK and Ireland, the Nordics, Benelux and Italy, which will expand our market opportunities and explore prospects for potential custom designs."

Acal BFi offer a broad range of power-supply products and technical expertise, as well as providing fully- and semi-customised power solutions and pre-compliance testing. The company's power portfolio ranges from 0,25W DC/DC converters to 5MW customised water-cooled AC/DC transformers.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered MRI predicts outcomes in prostate cancer